613 related articles for article (PubMed ID: 15906421)
1. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
[TBL] [Abstract][Full Text] [Related]
2. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
Nakata N; Wang Y; Bhatt S
Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
[TBL] [Abstract][Full Text] [Related]
3. Trends in state/population-based Down syndrome screening and invasive prenatal testing with the introduction of first-trimester combined Down syndrome screening, South Australia, 1995-2005.
Muller PR; Cocciolone R; Haan EA; Wilkinson C; Scott H; Sage L; Bird R; Hutchinson R; Chan A
Am J Obstet Gynecol; 2007 Apr; 196(4):315.e1-7; discussion 285-6. PubMed ID: 17403402
[TBL] [Abstract][Full Text] [Related]
4. Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing?
Hoskovec J; Mastrobattista JM; Johnston D; Kerrigan A; Robbins-Furman P; Wicklund CA
Prenat Diagn; 2008 Feb; 28(2):135-40. PubMed ID: 18236427
[TBL] [Abstract][Full Text] [Related]
5. Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study.
Qi QW; Jiang YL; Zhou XY; Liu JT; Yin J; Bian XM
Chin Med J (Engl); 2013; 126(11):2007-10. PubMed ID: 23769548
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older.
Vergani P; Locatelli A; Biffi A; Ciriello E; Zagarella A; Pezzullo JC; Ghidini A
Prenat Diagn; 2002 Sep; 22(9):769-74. PubMed ID: 12224068
[TBL] [Abstract][Full Text] [Related]
7. Women as moral pioneers? Experiences of first trimester antenatal screening.
Williams C; Sandall J; Lewando-Hundt G; Heyman B; Spencer K; Grellier R
Soc Sci Med; 2005 Nov; 61(9):1983-92. PubMed ID: 15899542
[TBL] [Abstract][Full Text] [Related]
8. First-trimester screening and its impact on uptake of diagnostic testing.
Darnes DR; Hashmi S; Monga M; Sullivan C; Vidaeff A; Berens P; Czerwinski JL
Prenat Diagn; 2011 Sep; 31(9):892-6. PubMed ID: 21692093
[TBL] [Abstract][Full Text] [Related]
9. Changes in the utilization of prenatal diagnosis.
Benn PA; Egan JF; Fang M; Smith-Bindman R
Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
[TBL] [Abstract][Full Text] [Related]
10. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects.
Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ
Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004
[TBL] [Abstract][Full Text] [Related]
11. Advanced maternal age as a sole indication for genetic amniocentesis; risk-benefit analysis based on a large database reflecting the current common practice.
Bornstein E; Lenchner E; Donnenfeld A; Barnhard Y; Seubert D; Divon MY
J Perinat Med; 2009; 37(2):99-102. PubMed ID: 18999912
[TBL] [Abstract][Full Text] [Related]
12. The use of record linkage for auditing the uptake and outcome of prenatal serum screening and prenatal diagnostic tests for Down syndrome.
Alberman E; Huttly W; Hennessy E; McIntosh A
Prenat Diagn; 2003 Oct; 23(10):801-6. PubMed ID: 14558023
[TBL] [Abstract][Full Text] [Related]
13. The importance of genetic counseling before amniocentesis.
Cohn GM; Gould M; Miller RC; Habecker-Green J; Macri CJ; Gimovsky ML
J Perinatol; 1996; 16(5):352-7; quiz 358-9. PubMed ID: 8915933
[TBL] [Abstract][Full Text] [Related]
14. Patient preferences for screening in the first trimester.
Werner EF; Pastore LM; Karns LB; Ventura KA; Saller DN
Prenat Diagn; 2008 Dec; 28(13):1251-5. PubMed ID: 19097030
[TBL] [Abstract][Full Text] [Related]
15. Options for Down syndrome screening: what will women choose?
Grant SS
J Midwifery Womens Health; 2005; 50(3):211-8. PubMed ID: 15894999
[TBL] [Abstract][Full Text] [Related]
16. Screening options for Down syndrome: how women choose in real clinical setting.
Lo TK; Lai FK; Leung WC; Lau WL; Ng LS; Wong WC; Tam SS; Yee YC; Choi H; Lam HS; Sham AS; Tang LC; Chin RK
Prenat Diagn; 2009 Sep; 29(9):852-6. PubMed ID: 19441088
[TBL] [Abstract][Full Text] [Related]
17. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
Sharda S; Phadke SR
J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
[TBL] [Abstract][Full Text] [Related]
18. Psychological responses to prenatal NTS counseling and the uptake of invasive testing in women of advanced maternal age.
Kaiser AS; Ferris LE; Katz R; Pastuszak A; Llewellyn-Thomas H; Johnson JA; Shaw BF
Patient Educ Couns; 2004 Jul; 54(1):45-53. PubMed ID: 15210259
[TBL] [Abstract][Full Text] [Related]
19. First-trimester combined screening for Down syndrome and other fetal anomalies.
O'Leary P; Breheny N; Dickinson JE; Bower C; Goldblatt J; Hewitt B; Murch A; Stock R
Obstet Gynecol; 2006 Apr; 107(4):869-76. PubMed ID: 16582125
[TBL] [Abstract][Full Text] [Related]
20. Health behaviour modelling for prenatal diagnosis in Australia: a geodemographic framework for health service utilisation and policy development.
Muggli EE; McCloskey D; Halliday JL
BMC Health Serv Res; 2006 Sep; 6():109. PubMed ID: 16945156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
